SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
992.00    44.00 (4.64%)
Bid:
972.00
Ask:
988.00
Spread: 16.00 (1.646%)
Market Cap: £271.52m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

AGM Trading Update

22 Feb 2023 07:00

RNS Number : 6201Q
Gooch & Housego PLC
22 February 2023
 

 

For immediate release

22 February 2023

 

Gooch & Housego PLC

("G&H", the "Group" or the "Company")

 

AGM Trading Update

 

"Significant progress made in adding productive capacity. Review of the Group's strategy progressing to plan. Trading in line with expectations."

 

Gooch & Housego PLC (AIM: GHH), the specialist manufacturer of photonic components & systems, will hold its Annual General Meeting at 11.00 a.m. today at the Company's headquarters in Ilminster, Somerset.

 

During the first four months of the financial year, the Group has made good progress in increasing its productive capacity as a result of our refocused recruitment and operational improvement activities. We are pleased to report that our UK production facilities are now fully resourced and, whilst we still have further roles to fill in some of our US facilities, the situation continues to improve. Our investment in inventory has helped protect our production programmes from persistent supply chain constraints. Consequently, the Group is making steady progress in lowering its lead-time for new orders received and reducing its overdue order book. The addition of productive capacity means that we now expect revenues to be more evenly balanced between the first and second halves of the financial year.

 

As previously reported, the Group continues to experience input cost inflation both in its employment costs and its supply chain. Whilst we are seeking to pass on these additional costs in our pricing, the size of the Group's order book means there will be some timing lag in this cost recovery. We, therefore, still expect inflation to have an impact on the Group's profitability in the current financial year.

 

Current year's trading continues to be in line with the Board's expectations.

 

As at 31 January 2023, our order book stood at £129.3 million (31 January 2022: £110.5 million), an increase of 17.0% compared with the same time last year but a reduction of 12.5% from the record level seen at the end of the previous financial year (30 September 2022: £147.7m). The improving levels of output have contributed to the order book reduction. We have also seen a moderation of order intake in parts of our Industrial and Life Science markets, with evidence of overstocking by some of our customers. Whilst we are alert to a potential market slow down, there remain multiple large value order opportunities for the Group's products and services that we expect to secure in the coming months and which will underpin expected revenues for FY2023 and beyond. 

 

The Group is refocusing investment into the development of earnings accretive new products with urgency to meet customer requirements. We are partnering with key customers in a number of areas including advanced semiconductor capacity expansion, directed energy systems, high power amplifiers for space communication and quantum based sensing, all of which are expected to provide the Group with profitable growth in the future.

 

Whilst we continue to invest in higher levels of inventory to protect our production programmes our receivables balance has reduced compared with the end of the previous financial year leading to a reduction in the Group's net debt position during the first four months of the financial year.

 

The review of the Group's strategy is progressing well and we expect to be able to provide more information at the time of the Group's interim results in June 2023.

 

 

Charlie Peppiatt, Chief Executive Officer of Gooch & Housego, commented:

 

"I am pleased with the initial progress in FY2023 from our initiatives to improve output, on-time delivery performance and lead times to meet customer expectations. We remain focused on further improvement across our production facilities as well as with our supply chain partners.

 

"There continues to be a significant level of positive technical interaction with our customers as we work with them on the development of their next generation photonics projects.

 

"The Group strategy review is progressing well and full year trading remains on track to meet the Board's expectations."

 

 

A slide deck to accompany the AGM can be viewed at the investor section of the Company's website, https://gandh.com/investors/

 

 

 

For further information please contact:

 

Charlie Peppiatt, Chief Executive Officer

Chris Jewell, Chief Financial Officer 

Gooch & Housego PLC

+44 (0) 1460 256440

 

Mark Court / George Cleary

G&H@buchanan.uk.com

Buchanan

+44 (0) 20 7466 5000

 

Christopher Baird / David Anderson

Investec Bank plc

+44 (0) 20 7597 5970

 

 

Notes to editors

 

1. Gooch & Housego is a photonics technology business headquartered in Ilminster, Somerset, UK with operations in the USA, Europe and China. A world leader in its field, the company researches, designs, engineers and manufactures advanced photonic systems, components and instrumentation for applications in the Aerospace & Defence, Industrial, Life Sciences and Scientific Research sectors. World leading design, development and manufacturing expertise is offered across a broad range of complementary technologies.

 

2. All financial information included in this announcement is sourced from unaudited management accounts and excludes any specific items. This announcement contains certain forward-looking statements that are based on management's current expectations or beliefs as well as assumptions about future events. These are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the countries and sectors in which G&H operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results, and G&H's plans and objectives, to differ materially from those currently anticipated or implied in the forward-looking statements. Investors should not place undue reliance on any such statements. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAMZGZZNMLGFZM
Date   Source Headline
3rd Jun 20267:00 amRNSDirectorate change
2nd Jun 20267:00 amRNSInterim Results
20th May 20267:00 amRNSNotice of Half Year Results
10th Apr 20262:25 pmRNSHolding(s) in Company
9th Apr 20267:00 amRNSHalf Year Trading Update
20th Mar 20263:16 pmRNSHolding(s) in Company
27th Feb 20262:23 pmRNSResult of AGM
27th Feb 20267:00 amRNSAGM Trading Update
2nd Feb 20267:00 amRNSChief Financial Officer appointment date
22nd Jan 20262:26 pmRNSHolding(s) in Company
13th Jan 20264:41 pmRNSHolding(s) in Company
12th Jan 20264:34 pmRNSPDMR notice
12th Jan 20263:30 pmRNSGrant of LTIP awards
9th Jan 20267:00 amRNSPDMR Notice and Issue of Equity
7th Jan 20267:00 amRNSPosting of Annual Report and Notice of AGM
12th Dec 20257:00 amRNSAppointment of Chief Financial Officer
2nd Dec 202511:36 amRNSDirector/PDMR Shareholding
2nd Dec 20257:00 amRNSResults for the year ended 30 September 2025
25th Nov 20257:00 amRNSNotification of Full Year Results
20th Nov 20252:14 pmRNSHolding(s) in Company
4th Nov 20257:07 amRNSDirectorate Update
8th Oct 20257:00 amRNSFurther Issue of Shares and TVR
7th Oct 20257:00 amRNSFull Year Trading Update
1st Oct 20252:15 pmRNSHolding(s) in Company
21st Jul 20257:00 amRNSChief Financial Officer Transition
15th Jul 20255:08 pmRNSHolding(s) in Company
30th Jun 20257:00 amRNSNotification of Major Holdings
23rd Jun 20252:30 pmRNSHolding(s) in Company - Replacement
20th Jun 202512:08 pmRNSHolding(s) in Company
18th Jun 20257:00 amRNSCompletion of Acquisition & Total Voting Rights
3rd Jun 20257:00 amRNSInterim Results
20th May 20257:00 amRNSNotification of Half Year Results
14th May 20257:00 amRNSAcquisition of Global Photonics
9th Apr 20252:16 pmRNSHolding(s) in Company
8th Apr 20257:00 amRNSHalf Year Trading Update
24th Feb 20252:19 pmRNSResult of AGM
24th Feb 20257:00 amRNSAGM Trading Update
7th Jan 20252:58 pmRNSGrant of LTIP Awards
6th Jan 202511:15 amRNSPosting of Annual Report and Notice of AGM
20th Dec 20243:15 pmRNSHolding(s) in Company
3rd Dec 20247:00 amRNSResults for the year ended 30 September 2024
4th Nov 20247:00 amRNSNotification of Full Year Results
30th Oct 20247:00 amRNSAcquisition of Phoenix Optical
28th Oct 20242:35 pmRNSHolding(s) in Company
8th Oct 20247:00 amRNSFull Year Trading Update
26th Sep 202410:31 amRNSDirector/PDMR Shareholding
23rd Aug 202412:52 pmRNSNotification of Major Holdings
16th Aug 20245:46 pmRNSHolding(s) in Company
16th Aug 20244:49 pmRNSHolding(s) in Company
15th Aug 20244:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.